Founded at the Abramson Cancer Center at the University of Pennsylvania

Association Between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer

Initiatives

Clinical Transformation

Association Between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cancer
JAMA | 2019
Ravi B. Parikh, MD, MPP; Blythe J. S. Adamson, PhD, MPH; Sean Khozin, MD, MPH; Matthew D. Galsky, MD; Shrujal S. Baxi, MD, MPH; Aaron Cohen, MD, MSCE; Ronac Mamtani, MD, MSCE